Anthony Carlo

An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19

Dafydd R. Owen, Charlotte Allerton, Annaliesa S. Anderson et al. · Science · 2021 · 1.9K citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5

Michael K. Ahlijanian, Nestor X. Barrezueta, Robert D. Williams et al. · Proceedings of the National Academy of Sciences · 2000 · 337 citations

Life Sciences, Neurobiology, Neuroscience +17

Anilinoquinazoline Inhibitors of Fructose 1,6-Bisphosphatase Bind at a Novel Allosteric Site:  Synthesis, In Vitro Characterization, and X-ray Crystallography

Stephen W. Wright, Anthony Carlo, Maynard D. Carty et al. · Journal of Medicinal Chemistry · 2002 · 82 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +17

A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19

Charlotte Allerton, Joel T. Arcari, Lisa Aschenbrenner et al. · Journal of Medicinal Chemistry · 2024 · 73 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15

Organic Anion Transporter 2–Mediated Hepatic Uptake Contributes to the Clearance of High-Permeability–Low-Molecular-Weight Acid and Zwitterion Drugs: Evaluation Using 25 Drugs

Emi Kimoto, Sumathy Mathialagan, Laurie Tylaska et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 55 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17